Science & Technology
HaloVax: Clay Nanotube-Based Vaccine Delivery Patches for the Sustained Release of an HIV Vaccine
Department of Defense — Defense Health Agency
Opportunity #: HT9425-25-P-0019
Award Ceiling
$250K
Award Floor
$250K
Close Date
Aug 26, 2025
Total Funding
$250K
Expected Awards
1
Posted Date
Jan 24, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-HT9425-25-P-0019
Description
SBIR Phase Phase I award: "HaloVax: Clay Nanotube-Based Vaccine Delivery Patches for the Sustained Release of an HIV Vaccine" awarded to GRAPHENO, LLC in SHREVEPORT, Louisiana. Funded by Department of Defense (Defense Health Agency). Award amount: $249,978.59. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.